CBER’s Long Goodbye: Biologics Approval Time Jumps To 30 Months In 2002

The average approval time for new biologic therapeutics and vaccines in 2002 was 30.1 months, an 11-month increase from 2001

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet